CLINICAL_TRIALS
trial_result
· 2014-09-09
Clinical Trial Update: Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients [Phase 1]
Summary
This Phase 1 study assesses the relative bioavailability of enzalutamide in patients with prostate cancer and the trial is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Europe B.V. | Conditions: Prostate Cancer, Pharmacokinetics of Enzalutamide | Phase 1 | Status: COMPLETED